Owners, management and financials
CVR: 34207283
Previous names: A/S PAS 2012 NR. 1007
DKK 8,717,034
Gross profit
Net result: DKK 2,113,161
Cell Biotech Co. Ltd. (100%)
CVR · view owners
Chung Myung Jun
Board: Yun Young Oak (chair) and 2 members
CVR · view management
Active
Founded 1 January 2012
CVR · view overview
9 employees
CVR · 2026
Owner registered: Cell Biotech Co. Ltd.
CVR · 23/06/2014
View the full event history
CELL BIOTECH INTERNATIONAL A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2012. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named A/S PAS 2012 NR. 1007. The management consists of Chung Myung Jun. The board consists of Yun Young Oak (chair), Chung Myung Jun and Chung Yu Sook. The company is owned by Cell Biotech Co. Ltd.. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 8,717,034 and a net result of DKK 2,113,161 compared with DKK 1,434,483 the year before. Equity in the 2025 report amounted to DKK 26,098,048.
Source: annual report 2025, Danish Business Authority
The financial health of CELL BIOTECH INTERNATIONAL A/S appears robust, with consistent growth in gross profit and profit over the past few years. Gross profit increased from 6.87 million DKK in 2021 to 8.72 million DKK in 2025, while profit rose from 1.90 million DKK to 2.11 million DKK in the same period, indicating a positive trajectory. The company's equity has significantly improved, reaching 26.1 million DKK in 2025, reflecting strong financial stability. However, the absence of revenue figures raises concerns about transparency and market positioning within the specialized goods trading industry. Overall, the company shows promising profitability and equity growth, positioning itself favorably despite the lack of disclosed revenue.
AI-generated summary · Generated 13/08/2026
Selskabets formål er salg og markedsføring af probiotika, kosmetik, kosttilskud og generelle fødevarer, køb af råvarer af probiotika, kosmetik, kosttilskud og generelle fødevarer,import og eksport af probiotika, kosmetik, kosttilskud og generelle fødevarer, import og eksport af råvarer af probiotika, kosmetik, kosttilskud og generelle fødevarer samt hermed beslægtede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 8.7 mio. | 2.1 mio. | 58.9 mio. | 26.1 mio. | 7 | |
| 202401/01/2024 – 31/12/2024 | 7 mio. | 1.4 mio. | 27.4 mio. | 16 mio. | 7 | |
| 202301/01/2023 – 31/12/2023 | 8.2 mio. | 2.7 mio. | 28.3 mio. | 14.6 mio. | 7 | |
| 202201/01/2022 – 31/12/2022 | 7.1 mio. | 2.4 mio. | 24.7 mio. | 11.9 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | 6.9 mio. | 1.9 mio. | 19.7 mio. | 9.5 mio. | 7 | |
| 202001/01/2020 – 31/12/2020 | 8.9 mio. | 3.1 mio. | 25 mio. | 7.6 mio. | 8 | |
| 201901/01/2019 – 31/12/2019 | 7.9 mio. | 853 t. | 26.7 mio. | 4.5 mio. | 7 | |
| 201801/01/2018 – 31/12/2018 | 7.9 mio. | 791 t. | 54.9 mio. | 3.6 mio. | 9 | |
| 201701/01/2017 – 31/12/2017 | 9 mio. | 1.5 mio. | 55.8 mio. | 2.8 mio. | 10 | |
| 201601/01/2016 – 31/12/2016 | 8.4 mio. | 583 t. | 15.6 mio. | 1.3 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 2.9 mio. | -3.2 mio. | 9.8 mio. | -5.6 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -2.1 mio. | -7.5 mio. | 7.2 mio. | -6.5 mio. | 5 | |
| 201301/01/2013 – 31/12/2013 | -1.2 mio. | -6 mio. | 9.5 mio. | -5.4 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 321 t. | -1.3 mio. | 9.8 mio. | -819 t. | 3 |
Compared to 159 companies in Agenturhandel med specialiseret varesortiment, bortset fra køretøjer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
2 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of CELL BIOTECH INTERNATIONAL A/S is 34207283.
CELL BIOTECH INTERNATIONAL A/S is owned by Cell Biotech Co. Ltd..
The management of CELL BIOTECH INTERNATIONAL A/S consists of Chung Myung Jun.
The board of CELL BIOTECH INTERNATIONAL A/S consists of Yun Young Oak, Chung Myung Jun and Chung Yu Sook, with Yun Young Oak as chair.
In 2025, CELL BIOTECH INTERNATIONAL A/S reported a gross profit of DKK 8,717,034.
CELL BIOTECH INTERNATIONAL A/S had 9 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 39775040, new email: [email protected] (July 2, 2026).
Contact info changed: new phone: 39775040, new email: [email protected] (May 26, 2026).
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2025. Gross profit came to DKK 8,717,034, and the net result was DKK 2,113,161.
As of May 13, 2025, Chung Yu Sook has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of May 13, 2025, Yoon Seong Bae has left the board of directors of CELL BIOTECH INTERNATIONAL A/S.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2024. Gross profit came to DKK 7,032,335, and the net result was DKK 1,434,483.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2023. Gross profit came to DKK 8,247,899, and the net result was DKK 2,650,797.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2022. Gross profit came to DKK 7,093,741, and the net result was DKK 2,411,256.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2021. Gross profit came to DKK 6,870,416, and the net result was DKK 1,898,678.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2020. Gross profit came to DKK 8,899,568, and the net result was DKK 3,104,779.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2019. Gross profit came to DKK 7,942,395, and the net result was DKK 852,612.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2018. Gross profit came to DKK 7,872,118, and the net result was DKK 791,370.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2017. Gross profit came to DKK 9,039,709, and the net result was DKK 1,536,436.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2016. Gross profit came to DKK 8,381,536, and the net result was DKK 583,487.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2015. Gross profit came to DKK 2,855,326, and the net result was DKK -3,198,970.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2014. Gross profit came to DKK -2,057,162, and the net result was DKK -7,540,709.
As of June 23, 2014, is registered as an owner of CELL BIOTECH INTERNATIONAL A/S with an ownership share of 100%.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2013. Gross profit came to DKK -1,187,571, and the net result was DKK -6,049,245.
CELL BIOTECH INTERNATIONAL A/S has published its annual report for 2012. Gross profit came to DKK 321,368, and the net result was DKK -1,319,287.
As of April 10, 2012, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of CELL BIOTECH INTERNATIONAL A/S.
As of April 10, 2012, EY Godkendt Revisionspartnerselskab has stepped down as auditor of CELL BIOTECH INTERNATIONAL A/S.
As of January 26, 2012, Yun Young Oak has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 26, 2012, Young Oak Yun has left the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, EY Godkendt Revisionspartnerselskab has been appointed auditor of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Young Oak Yun has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Yoon Seong Bae has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Chung Myung Jun has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Peter Andreas Stakemann has left the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Thomas Jeffrey Malherbes Gullacksen has left the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Ulf Lund has left the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Chung Myung Jun is registered as director of CELL BIOTECH INTERNATIONAL A/S.
As of January 18, 2012, Peter Andreas Stakemann has stepped down as director of CELL BIOTECH INTERNATIONAL A/S.
On January 18, 2012, the company changed its name from A/S PAS 2012 NR. 1007 to CELL BIOTECH INTERNATIONAL A/S.
As of January 1, 2012, Peter Andreas Stakemann has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 1, 2012, Thomas Jeffrey Malherbes Gullacksen has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 1, 2012, Ulf Lund has joined the board of directors of CELL BIOTECH INTERNATIONAL A/S.
As of January 1, 2012, Peter Andreas Stakemann is registered as director of CELL BIOTECH INTERNATIONAL A/S.
CELL BIOTECH INTERNATIONAL A/S was founded on January 1, 2012.
Companies in the same industry and area
CVR 25472020
CVR 13612870
CVR 26611296
CVR 35060804
CVR 46179080
